对术后肝转移的积极预防和治疗是提高远端胆管癌生存率的重要策略。
Aggressive treatment and prevention on postoperative liver metastasis is a important strategy to improve the survival for distal bile duct cancer.
目的探讨胰体尾癌肝转移的外科治疗方法和预后的影响因素。
Objective To explore surgery therapy and the prognosis of pancreatic body and tail cancer with hepatic metastasis.
癌组织中VEGF-C的表达与门静脉癌栓、肝门淋巴结转移和复发有关（P<0.05）。
The expression of VEGF-C was correlated with portal vein-emboli, lymph node metastasis and recurrence(P<0.05).
新的抗癌药物和其它药物的推出可增加肝转移癌的切除机会，并延长晚期患者的生存期。
The availability of new cytostatic agents and other drugs may improve the resectability of liver metastases and prolong the survival in advanced disease.
本组肝脏胆管上皮癌1例，肝转移性癌3例，肝炎8例和肝硬化22例，其AFP均阴性。
In this group 1 cholangiocellular carcinoma, 3 metastatic tumors of liver, 8 hepatitis and 22 cirrhosis were AFP-negative.
在肝转移的进展期癌中，MACC1和MET表达都增强。
Both MACC1 and met expression were enhanced in advanced carcinoma with liver metastasis.
结论：肝内胆管细胞癌cd 151表达与其恶性表型相关，可能参与其侵袭和转移。
Conclusions: The overexpression of CD151 was correlated with malignant phenotype of intra hepatic cholangiocarcinoma and probably implicated in invasion and metastasis.
结论：肝内胆管细胞癌cd 151表达与其恶性表型相关，可能参与其侵袭和转移。
Conclusions: The overexpression of CD151 was correlated with malignant phenotype of intra hepatic cholangiocarcinoma and probably implicated in invasion and metastasis.
应用推荐